Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

January 15, 2021

Synthetic Ion Channel Formed by Multiblock Amphiphile with Anisotropic Dual-Stimuli-Responsiveness

Journal of the American Chemical Society
Ryo SasakiKazushi Kinbara
January 13, 2021

Towards a broad-spectrum flavivirus vaccine

Nature Reviews. Drug Discovery
Sarah Crunkhorn
January 12, 2021
Case Report
Open Access

A new method of superior vena cava isolation without phrenic nerve injury by longitudinal ablation parallel to the phrenic nerve: a case report

European Heart Journal. Case Reports
Tomoyuki AraiSeiji Fukamizu
January 9, 2021

Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease

Journal of the American College of Cardiology
Abbasin ZegardFrancisco Leyva
January 11, 2021
Review

Major publications in the critical care pharmacotherapy literature: 2019

Journal of Critical Care
Melanie Smith CondeniAndrea Sikora Newsome
January 13, 2021

Small molecule combination treats snakebite

Nature Reviews. Drug Discovery
Sarah Crunkhorn
January 16, 2021
Open Access

Catecholaminergic polymorphic ventricular tachycardia complicated by dilated cardiomyopathy: a case report

European Heart Journal. Case Reports
Granitz ChristinaPölzl Gerhard
January 15, 2021

Sarepta's DMD gene therapy falls flat

Nature Reviews. Drug Discovery
Asher Mullard
January 5, 2021
Open Access

Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing

Frontiers in Cardiovascular Medicine
Lan SuWeijian Huang
January 13, 2021

Clinical characteristics and stratification of the cerebrovascular accident risk among patients with atrial fibrillation in Colombia, 2011-2016

Expert Review of Cardiovascular Therapy
Diego Alejandro Medina-MoralesJorge Enrique Machado-Alba
January 16, 2021

Biopharma dealmaking in 2020

Nature Reviews. Drug Discovery
Patricia Giglio, Amanda Micklus
January 15, 2021

Half-normal saline vs normal saline for irrigation of open-irrigated radiofrequency catheters in atrial fibrillation ablation

Journal of Cardiovascular Electrophysiology
Carola GianniAndrea Natale
January 9, 2021

Cryoballoon Versus Laserballoon: Insights from the First Prospective Randomized Balloon Trial in Catheter Ablation of Atrial Fibrillation

Circulation. Arrhythmia and Electrophysiology
Julian K R ChunBoris Schmidt
January 15, 2021

Tezepelumab prepares to enter the asthma antibody fray

Nature Reviews. Drug Discovery
Asher Mullard
January 1, 2021
Open Access

Blockade of sodium‑calcium exchanger via ORM-10962 attenuates cardiac alternans

Journal of Molecular and Cellular Cardiology
Jozefina SzlovákNorbert Nagy
January 12, 2021

An exploratory analysis of effects of poyendarone, a deuterated analogue of dronedarone, on the canine model of paroxysmal atrial fibrillation

Naunyn-Schmiedeberg's Archives of Pharmacology
Ryuichi KambayashiAtsushi Sugiyama
January 16, 2021

Suppressing autoimmunity with mRNA vaccines

Nature Reviews. Drug Discovery
M Teresa Villanueva
January 10, 2021

Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines: Atrial Fibrillation Registry

Circulation. Arrhythmia and Electrophysiology
Michael E FieldJonathan P Piccini

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2021 Meta ULC. All rights reserved
/feed-previews/anti-arrhythmic-drug-therapies/af845480-c389-4372-aea0-be8b874e32c6